Clinical Trials
5
Active:0
Completed:4
Trial Phases
2 Phases
Phase 4:3
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 4
3 (60.0%)Not Applicable
2 (40.0%)Ramadan Fasting Outcomes in Patients with Secondary Adrenal Insufficiency Before and After the Treatment of Hypotension.
Phase 4
Not yet recruiting
- Conditions
- Secondary Adrenal InsufficiencyHypotension
- Interventions
- First Posted Date
- 2025-02-18
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- Hopital La Rabta
- Target Recruit Count
- 20
- Registration Number
- NCT06832566
- Locations
- 🇹🇳
Hopital La Rabta, Tunis, Tunisia
Risks of Intermittent Fasting in Patients With Primary Adrenal Insufficiency
Not Applicable
Completed
- Conditions
- Primary Adrenal InsufficiencyIntermittent Fasting
- First Posted Date
- 2024-03-07
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Hopital La Rabta
- Target Recruit Count
- 30
- Registration Number
- NCT06299020
- Locations
- 🇹🇳
Hôpital La Rabta, Tunis, Tunisia
Ramadan Fasting in Secondary Adrenal Insufficiency Patients
Not Applicable
Completed
- Conditions
- Secondary Adrenal InsufficiencyFasting, Intermittent
- First Posted Date
- 2023-04-25
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Hopital La Rabta
- Target Recruit Count
- 63
- Registration Number
- NCT05827965
- Locations
- 🇹🇳
University Hospital La Rabta, Tunis, Tunisia
Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men
Phase 4
Completed
- Conditions
- Adrenal InsufficiencyDiabetes Mellitus, Type 2Hypogonadism, MaleVitamin D DeficiencyDyslipidemia Associated With Type II Diabetes MellitusStatin Adverse Reaction
- Interventions
- First Posted Date
- 2023-04-10
- Last Posted Date
- 2023-04-10
- Lead Sponsor
- Hopital La Rabta
- Target Recruit Count
- 104
- Registration Number
- NCT05806723
- Locations
- 🇹🇳
University Hospital La Rabta, Tunis, Tunisia
Comparative Study of Efficacy and Safety of Oral Ibuprofen and Intravenous Ibuprofen in Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants
Phase 4
Completed
- Conditions
- Patent Ductus Arteriosus
- Interventions
- First Posted Date
- 2008-03-25
- Last Posted Date
- 2008-03-25
- Lead Sponsor
- Hopital La Rabta
- Target Recruit Count
- 62
- Registration Number
- NCT00642330
- Locations
- 🇹🇳
Maternity and Neonatal Center, Tunis, Tunisia
News
No news found